Alternatives to Norethindrone for Menorrhagia with Regular Cycles
For menorrhagia in women with regular cycles who cannot take norethindrone, combined hormonal contraceptives (CHCs) or the levonorgestrel-releasing intrauterine system (LNG-IUS) are the most effective first-line alternatives, with tranexamic acid and NSAIDs as additional non-hormonal options.
Primary Hormonal Alternatives
Combined Hormonal Contraceptives (CHCs)
CHCs are a guideline-recommended first-line medical treatment for menorrhagia 1. These include oral contraceptive pills, patches, or vaginal rings. They work by stabilizing the endometrium and reducing menstrual blood flow. CHCs are particularly appropriate for women with regular cycles who also desire contraception and have no contraindications (such as migraine with aura, thromboembolism risk, or age >35 with smoking).
Levonorgestrel-Releasing Intrauterine System (LNG-IUS)
The LNG-IUS is the most effective medical treatment for menorrhagia, reducing menstrual blood loss by 94% compared to baseline 2. A systematic review demonstrated that the LNG-IUS was superior to conventional medical treatments including norethindrone, with higher patient satisfaction (76% wished to continue vs. 22% with norethindrone) and lower discontinuation rates 3, 2. This is an excellent option for women who cannot tolerate oral progestins or desire long-acting reversible contraception.
Non-Hormonal Alternatives
Tranexamic Acid (First-Line Non-Hormonal)
Tranexamic acid is the most effective non-hormonal option, reducing menstrual blood loss by 45% and normalizing bleeding in 56% of women 4. It is taken only during menstruation (typically 1g four times daily for days 1-4 of the cycle) 5. This antifibrinolytic agent is particularly useful for women who:
- Cannot or prefer not to use hormonal treatments
- Have contraindications to estrogen or progestins
- Desire to maintain natural ovulatory cycles
Tranexamic acid was significantly more effective than norethindrone in head-to-head trials 4.
NSAIDs (Mefenamic Acid, Ibuprofen, Naproxen)
NSAIDs reduce menstrual blood loss by approximately 20-30% and are taken only during menstruation (typically 5-7 days) 5. Mefenamic acid (500mg three times daily during menses) showed similar efficacy to norethindrone in reducing blood loss 6, though both left over 50% of women still menorrhagic. NSAIDs have the added benefit of treating dysmenorrhea. However, they are less effective than tranexamic acid or the LNG-IUS 7.
Treatment Algorithm
Step 1: Determine if hormonal contraception is acceptable and medically appropriate
- If yes and contraception desired: CHCs or LNG-IUS (LNG-IUS preferred for superior efficacy)
- If yes but no contraception desired: LNG-IUS still preferred due to superior efficacy
Step 2: If hormonal options are contraindicated or declined
- First choice: Tranexamic acid (1g four times daily during menstruation)
- Second choice or adjunct: NSAIDs (mefenamic acid 500mg three times daily during menstruation)
Step 3: If medical management fails
- Consider endometrial ablation or hysterectomy 1
Important Caveats
Norethindrone at standard doses (5mg 2-3 times daily on days 19-26) is actually relatively ineffective for ovulatory menorrhagia, with studies showing it normalized bleeding in only 9.5% of women 4 and was significantly less effective than both tranexamic acid and danazol 4, 8.
The evidence shows that luteal-phase progestins (like norethindrone given days 19-26) are generally ineffective for menorrhagia with regular cycles 4, 6, 2. This is why alternatives are often more successful.
Before initiating treatment, ensure structural causes (fibroids, polyps, adenomyosis) and coagulopathies have been ruled out, as these may require different management 1.
For women with obesity or very heavy bleeding, higher doses of hormonal treatments may be needed to achieve menstrual suppression 9.